ATHEROABZYME Trademark

Trademark Overview

On Friday, December 21, 2007, a trademark application was filed for ATHEROABZYME with the United States Patent and Trademark Office. The USPTO has given the ATHEROABZYME trademark a serial number of 79049471. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, December 21, 2017. This trademark is owned by Cambridge Theranostics Limited. The ATHEROABZYME trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic substances, reagents and preparations for medical use; diagnostic kits consisting primarily of diagnostic substances, reagents and preparations for medical use and for use in disease testing; diagnostic testing materials for medical use, namely, reagents and media for use in relation to human beings who have or are at risk of developing atherosclerotic conditions, cardiovascular conditions, metabolic syndromes, diabetes, hypertension, strokes, coronary diseases, heart diseases, heart failure, peripheral artery occlusive disease; diagnostic testing materials for medical use, namely, reagents and media for testing the blood; diagnostic testing materials for medical use, namely, lipid lycoproteins, blood serums, plasma, immobilized lipid antigens; chemical products for medical diagnostic use, namely, reagents and media for use in relation to human beings who have or are at risk of developing atherosclerotic conditions, cardiovascular conditions, metabolic syndromes, diabetes, h...
atheroabzyme

General Information

Serial Number79049471
Word MarkATHEROABZYME
Filing DateFriday, December 21, 2007
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateThursday, December 21, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic substances, reagents and preparations for medical use; diagnostic kits consisting primarily of diagnostic substances, reagents and preparations for medical use and for use in disease testing; diagnostic testing materials for medical use, namely, reagents and media for use in relation to human beings who have or are at risk of developing atherosclerotic conditions, cardiovascular conditions, metabolic syndromes, diabetes, hypertension, strokes, coronary diseases, heart diseases, heart failure, peripheral artery occlusive disease; diagnostic testing materials for medical use, namely, reagents and media for testing the blood; diagnostic testing materials for medical use, namely, lipid lycoproteins, blood serums, plasma, immobilized lipid antigens; chemical products for medical diagnostic use, namely, reagents and media for use in relation to human beings who have or are at risk of developing atherosclerotic conditions, cardiovascular conditions, metabolic syndromes, diabetes, hypertension, strokes, coronary diseases, heart diseases, heart failure, peripheral artery occlusive disease; chemical products for medical diagnostic use, namely, reagents and media for testing the blood; chemical products for medical diagnostic use, namely, lipid lycoproteins, blood serums, plasma, immobilized lipid antigens

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, December 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCamNutra Limited
Party Type11 - New Owner Before Publication
Legal Entity Type98 - Unknown
AddressGB
Party NameCambridge Theranostics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Saturday, July 21, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, July 20, 2018DEATH OF INTERNATIONAL REGISTRATION
Thursday, September 10, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 3, 2013CHANGE OF OWNER RECEIVED FROM IB
Saturday, September 8, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 20, 2012FINAL DISPOSITION NOTICE SENT TO IB
Sunday, August 19, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 19, 2011ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Monday, July 25, 2011ABANDONMENT - AFTER EX PARTE APPEAL
Monday, July 25, 2011EXPARTE APPEAL TERMINATED
Tuesday, May 10, 2011EX PARTE APPEAL-REFUSAL AFFIRMED
Thursday, November 18, 2010EXAMINERS STATEMENT MAILED
Thursday, November 18, 2010EXAMINERS STATEMENT - COMPLETED
Monday, September 20, 2010JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, January 7, 2010SUBSEQUENT FINAL MAILED
Thursday, January 7, 2010SUBSEQUENT FINAL MAILED
Wednesday, January 6, 2010SUBSEQUENT FINAL REFUSAL WRITTEN
Wednesday, December 2, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 2, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 2, 2009TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, December 2, 2009EX PARTE APPEAL-INSTITUTED
Wednesday, December 2, 2009JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, December 2, 2009EXPARTE APPEAL RECEIVED AT TTAB
Thursday, August 27, 2009NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, August 7, 2009NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, August 6, 2009NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, June 4, 2009FINAL REFUSAL MAILED
Wednesday, June 3, 2009FINAL REFUSAL WRITTEN
Monday, May 11, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 11, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 13, 2008NON-FINAL ACTION MAILED
Thursday, November 13, 2008NON-FINAL ACTION WRITTEN
Monday, October 20, 2008AMENDMENT FROM APPLICANT ENTERED
Monday, October 20, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 17, 2008ASSIGNED TO LIE
Wednesday, October 1, 2008PAPER RECEIVED
Thursday, April 24, 2008REFUSAL PROCESSED BY IB
Tuesday, April 1, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 1, 2008REFUSAL PROCESSED BY MPU
Tuesday, April 1, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 31, 2008NON-FINAL ACTION WRITTEN
Thursday, March 27, 2008ASSIGNED TO EXAMINER
Friday, March 7, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, March 6, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

atheroabzyme diagnostic medical testing reagents namely conditions media materials atherosclerotic metabolic